Bologna, Italy — May 8 to 10, 2026. Over 300 companies gathered at Cosmofarma Exhibition, the leading European trade fair for pharmacy, healthcare, and beauty care. Beneath the product launches, the regulatory updates, and the networking, one message rang louder than any other: antimicrobial resistance is accelerating — and the pharmacy counter is part of the problem.

At the event, the Italian Ministry of Health and the Istituto Superiore di Sanità (ISS) maintained a dedicated area addressing healthcare-associated infections and AMR. The message was unambiguous: Italy remains one of the worst-performing countries in Europe for drug-resistant pathogen control, and community-facing healthcare settings — pharmacies chief among them — are underprotected.

This article explains why surface hygiene in pharmacies is a critical but overlooked link in the AMR chain, what the evidence says about pathogen persistence on retail surfaces, and what a practical, science-backed protection protocol looks like in 2026.

The AMR Crisis: Where Italy Stands in 2026

Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi, and parasites evolve mechanisms to defeat the drugs designed to kill them. The result: infections that were once easily treatable become life-threatening. According to the WHO Global Antibiotic Resistance Surveillance Report (2025), one in six lab-confirmed bacterial infections worldwide is now resistant to standard first-line treatments.

In Europe, the picture is stark. The European Centre for Disease Prevention and Control (ECDC) estimates that more than 35,000 people die from AMR-related infections in the EU every year — roughly equivalent to the combined toll of influenza, HIV, and tuberculosis. Of those deaths, approximately one third occur in Italy, making it the worst-affected large economy in the bloc.

AMR is not only a hospital problem. It follows patients — and pathogens — into every healthcare-adjacent environment. Pharmacies are precisely that: the daily interface between the community and the clinical world, touched by the healthy and the ill alike, hundreds of times per day.

The Pharmacy Counter: An Overlooked AMR Reservoir

Walk into any pharmacy. Customers lean on the counter. They hand over prescription packaging, tap debit terminals, handle blister packs, turn product bottles to read the label. A single person with an active MRSA colonisation — often entirely asymptomatic — can deposit tens of thousands of viable bacterial cells on a surface in a single interaction.

Now consider what happens to those cells between cleaning cycles. Unlike hospital environments, most community pharmacies are cleaned one to three times per day. In a busy pharmacy serving 200 patients daily, that means each surface has hours of unprotected exposure between disinfection events.

Drug-Resistant Pathogens Confirmed on Pharmacy Surfaces

The data above reflects peer-reviewed findings from clinical microbiology literature. The critical takeaway: standard disinfectants applied once or twice daily do not cover the exposure window. Every hour between a disinfection event and the next is an hour during which a deposited pathogen can survive — and transfer to the next patient who touches that surface.

Why Standard Disinfection Alone Is Not Enough

Standard disinfection — whether alcohol-based, quaternary ammonium, or chlorine-based — is highly effective at the moment of application. Within seconds to minutes, it reduces bacterial and viral loads on surfaces by 99.9% or more. No serious professional disputes this.

The problem is temporal. Disinfectants are active for minutes, not hours. The moment a cleaned surface is touched by the next customer’s hand, the protection is functionally over. In a pharmacy with 30 patients per hour, the average counter may be contaminated again within two minutes of disinfection.

This distinction is central to infection control science, and it is increasingly recognized in guidelines from the WHO, ECDC, and national health ministries. The 2026 direction is clear: the future of surface hygiene is layered protection — scheduled disinfection plus continuous antimicrobial surface activity.

What Cosmofarma 2026 Confirmed About Pharmacy Hygiene

The 29th edition of Cosmofarma Exhibition, held in Bologna under the theme “Regeneration / NewGeneration”, drew over 300 exhibitors and thousands of pharmacy professionals from across Italy and Europe. Beyond product innovation and business strategy, the event had a clear scientific undercurrent: the pharmacy of the future must be built on integrated health and hygiene.

The Ministry of Health and the ISS presence at the event — specifically focused on AMR and healthcare-associated infections — sent an unmistakable signal to every pharmacy operator in attendance. AMR prevention is no longer a hospital-only concern. It is a community-level obligation that starts at the pharmacy counter.

For VireXbuster, Cosmofarma 2026 was both a validation and a call to action. The conversation that pharmacy professionals are now having — about surface transmission, about AMR stewardship, about the limits of cleaning schedules — is precisely the conversation we have been driving since our founding in Eschborn, Germany.

The VireXbuster Protocol: Layered Surface Protection for Pharmacies

VireXbuster is not a disinfectant. It is a hybrid antimicrobial surface coating with a very wide spectrum of activity against viruses, bacteria, fungi, mold, and mildew. Applied to pharmacy surfaces, it provides continuous supplemental protection between disinfection events — filling precisely the gap that standard protocols leave open.

The recommended implementation for pharmacy environments follows a three-layer logic:

• Layer 1 — Scheduled disinfection: Maintain your existing cleaning protocol. VireXbuster does not replace it. Professional-grade disinfection at opening, midday, and closing remains the foundation.
• Layer 2 — VireXbuster surface coating: Apply VireXbuster Spray or Wall to all high-touch surfaces: counter tops, dispensing trays, keyboard covers, door handles, and shelving edges. The coating acts continuously between cleaning cycles.
• Layer 3 — HVAC protection (where applicable): VireXbuster HVAC addresses the aerosol transmission vector by treating the air handling system — reducing airborne pathogen load across the entire pharmacy floor.

VireXbuster Product Range

All prices are exclusive of VAT. DaXem GmbH ships from Eschborn, Germany, across the European Union. For volume pricing for pharmacy groups and distributors, contact info@daxem.de.

Practical Steps: What Every Pharmacy Should Do This Week

AMR is not a problem that waits for a strategic planning cycle. The pathogens are already there. The patients are already touching your surfaces. Here is a concrete five-step action plan that any pharmacy can implement immediately:

• Audit your current cleaning frequency. If high-touch surfaces are not being wiped down at least three times per operational day, increase the schedule. This is baseline.
• Map your highest-risk surfaces. Counter tops, digital payment terminals, prescription drop-off trays, and door handles are your priority zones. These are the surfaces most likely to harbour drug-resistant pathogens between cleaning cycles.
• Introduce a continuous antimicrobial layer. Apply VireXbuster Spray to all mapped surfaces. The coating is invisible, does not affect product presentation, and works around the clock.
• Train staff on the gap risk. Every pharmacy team member should understand that disinfection protects surfaces for minutes, not hours — and that patient contact resets the clock. This awareness drives better practice.
• Document and review. Keep a hygiene log. Review AMR-related incidents quarterly. Surface protection is a continuous commitment, not a one-time purchase.

Frequently Asked Questions

Conclusion: The Pharmacy of the Future Is a Safe Pharmacy

The data from 2026 is not new — AMR scientists have been warning about drug-resistant surface reservoirs for more than a decade. What is new is the urgency. One in six bacterial infections is now resistant to standard treatment. Italy accounts for a disproportionate share of EU deaths from AMR. And every unprotected pharmacy counter is a node in the transmission chain.

The answer is not more disinfectant. The answer is smarter, layered protection: scheduled disinfection plus a continuous antimicrobial surface coating that works in the hours between cleaning events. This is not a theoretical solution — it is available now, from VireXbuster by DaXem GmbH.

If you are a pharmacy owner, operator, or procurement manager, the question to ask yourself is simple: what is protecting your surfaces right now, at this moment, between yesterday’s cleaning and tomorrow’s opening? If the answer is nothing — it is time to act.